Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Boardroom

Executive Compensation

Effective compensation programs must attract and retain key executives while balancing the interests of employers and equity holders. We work with our clients on a wide range of compensation arrangements in both an ongoing advisory role and in significant corporate events, such as mergers, acquisitions and initial public offerings. The firm has crafted hundreds of executive pay and board member packages in a climate of changing legal demands and controversy. 

Amid increasing scrutiny of executive compensation, we advise our public company clients and their compensation committees on a wide array of issues involving executive compensation, including:

  • Executive compensation program structure 
  • Say-on-pay considerations 
  • U.S. Securities and Exchange Commission (SEC) disclosure requirements 
  • Proxy statement disclosures 
  • National securities exchange listed company standards 
  • SEC regulatory developments such as those related to pay ratio disclosure and other Dodd-Frank Act requirements 
  • Proxy advisory firm policies

We counsel public and private companies, individual executives, boards of directors, management teams, private equity and venture capital funds, financial institutions, and tax-exempt organizations with respect to the design and implementation of a full range of compensation arrangements, including:

  • Equity incentive plans and awards 
  • Executive employment agreements 
  • Management incentive compensation programs 
  • Supplemental executive retirement plans and other non-qualified deferred compensation plans 
  • Director compensation arrangements 
  • Severance agreements and policies 
  • Clawback policies

News

View More

Related Experiences

View More

Related Professionals

NAME TITLE TELEPHONE CONTACT

Viewing 0 of 0 Results

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Services

×

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.